CUSIP: 89620X506
Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
6,825,503
-
Share change
-
+141,999
-
Total reported value
-
$2,098,020
-
Price per share
-
$0.31
-
Number of holders
-
17
-
Value change
-
+$42,662
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q3 2019
As of 30 Sep 2019,
TRILLIUM THERAPEUTICS INC - COM NEW was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,825,503 shares.
The largest 10 holders included
Matrix Capital Management Company, LP, NEA Management Company, LLC, MORGAN STANLEY, BAKER BROS. ADVISORS LP, Tekla Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, CITADEL ADVISORS LLC, UBS Group AG, and TWO SIGMA ADVISERS, LP.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.